Clinical Trials
8 trialsNCT05085548 2026-04-27
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
ProDa BioTech, LLC
Phase 1 Completed
NCT03889795 2025-10-20
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
University of Toledo
Phase 1 Active not recruiting
NCT05657418 2025-06-06
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT04796948 2025-04-29
A Study of Irinotecan Liposome in Advanced Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT04928625 2021-08-24
A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04707118 2021-01-13
Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy
Fudan University
Phase 1 Unknown
NCT02101580 2020-10-01
Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer
Polaris Group
Phase 1 Completed
NCT04482257 2020-07-22
Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown